Altshuler Shaham LTD Cellectis S.A. Transaction History

Altshuler Shaham LTD

  • $1.57 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$15.53 - $19.75 $614,801 - $781,863
-39,588 Closed
0 $0
Q4 2018

Feb 11, 2019
SELL
$15.58 - $28.41 $1,744 - $3,181
-112 Reduced 0.28%
39,588 $659,000
Q3 2018

Nov 13, 2018
BUY
$25.99 - $30.6 $1.03 Million - $1.21 Million
39,700 New
39,700 $1.12 Million

Others Institutions Holding CLLS

# of Institutions
30
Shares Held
10.8M
Call Options Held
5.9K
Put Options Held
1.4K
View Full List

About Cellectis S.A.

CLLS Quotes by TradingView
  • Ticker CLLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,510,800
  • Market Cap $71M
  • Description
  • Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...
More about CLLS
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email